Gut bacterial surface antigen

Gut bacterial surface antigens are a heterogeneous group of molecules, such as lipopolysaccharides, peptidoglycans, and flagellins, that constitute the outer layer of the intestinal microbiota. These molecules act as potent immunomodulators by interacting with host pattern recognition receptors (PRRs), including Toll-like receptors (TLRs), to regulate mucosal immunity and intestinal barrier function (Sartor, 2008, Gastroenterology). In conditions like Crohn's disease and ulcerative colitis, the loss of tolerance to these commensal antigens triggers a persistent inflammatory cascade, making them significant targets for diagnostic and therapeutic development (Vindigni et al., 2016, J Clin Gastroenterol). Current pharmacological approaches focus on neutralizing these antigens or blocking their interaction with host cells to mitigate inflammation or prevent pathogen colonization. For instance, FimH antagonists like sibofimloc are designed to prevent the adhesion of pro-inflammatory Escherichia coli to the intestinal mucosa (Spaunhurst et al., 2022). Additionally, serum antibodies against specific bacterial surface proteins, such as OmpC and flagellin (Cbir1), serve as critical biomarkers for disease stratification and prognosis in inflammatory bowel disease (Hansen et al., 2010, Curr Opin Gastroenterol).

Other names

Commensal bacterial antigensMicrobiota-associated molecular patternsMAMPsBacterial cell wall componentsSurface-exposed bacterial proteins

Neutralization of bacterial ligands, inhibition of bacterial adhesion to host cells, and modulation of Toll-like receptor (TLR) signaling pathways.